Comparison of Hepatic Artery Embolization and Selective Internal Radiation Therapy for Metastatic Neuroendocrine Tumors

被引：0
|
作者：
Engelman, Eric S. [1 ,2 ]
Leon-Ferre, Roberto [3 ]
Naraev, Boris G. [1 ,2 ]
Sharma, Nancy [1 ,2 ]
Sun, Shiliang [4 ]
O'Dorisio, Thomas M. [2 ,5 ]
Halfdanarson, Thorvardur R. [1 ,2 ]
机构：
[1] Univ Iowa Hosp & Clin, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA 52242 USA
[2] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[3] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA
[4] Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA
[5] Univ Iowa Hosp & Clin, Div Endocrinol & Metab, Iowa City, IA 52242 USA
来源：
PANCREAS | 2012年 / 41卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：345 / 345
页数：1
相关论文
共 50 条
  • [21] Hepatic arterial embolization in patients with neuroendocrine tumors
    Del Prete, Michela
    Fiore, Francesco
    Modica, Roberta
    Marotta, Vincenzo
    Marciello, Francesca
    Ramundo, Valeria
    Di Sarno, Antonella
    Carratu, Annachiara
    di Roseto, Chiara de Luca
    Tafuto, Salvatore
    Tatangelo, Fabiana
    Baldelli, Robero
    Colao, Annamaria
    Faggiano, Antongiulio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [22] Phase II Study of Sunitinib following Hepatic Transarterial Embolization for Metastatic Neuroendocrine Tumors
    Strosberg, J.
    Cheema, A.
    Campos, T.
    Kvols, L.
    NEUROENDOCRINOLOGY, 2011, 94 : 46 - 46
  • [23] Selective internal radiation therapy of hepatic tumours: Is coiling of the gastroduodenal artery always beneficial?
    Schelhorn, J.
    Theysohn, J.
    Ertle, J.
    Schlaak, J. F.
    Mueller, S.
    Bockisch, A.
    Lauenstein, T.
    CLINICAL RADIOLOGY, 2014, 69 (05) : E216 - E222
  • [24] Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Strosberg, J.
    Campos, T.
    Kvols, L.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 136 - 136
  • [25] Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes
    Pericleous, Marinos
    Caplin, Martyn E.
    Tsochatzis, Emmanuel
    Yu, Dominic
    Morgan-Rowe, Luke
    Toumpanakis, Christos
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : 61 - 69
  • [26] Angiogenesis Markers after Hepatic Artery Embolization of Liver Metastases in Patients with Neuroendocrine Tumors
    Korse, C. M.
    Bonfrer, J. M.
    Taal, B. G.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 41 - 41
  • [27] Combined Peptide Radio-Receptor Therapy (PRRT) And Liver Selective Internal Radiation Therapy (SIRT) In Patients With Metastatic Neuroendocrine Tumors: Which Is The Best Sequence?
    Follacchio, G. A.
    Maccauro, M.
    Pusceddu, S.
    Lorenzoni, A.
    Mira, M.
    Prinzi, N.
    Chiesa, C.
    Capozza, A.
    Spreafico, C.
    Aliberti, G.
    Bhoori, S.
    Marchiano, A.
    Seregni, E.
    Mazzaferro, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S591 - S591
  • [28] Selective Internal Radiotherapy with Yttrium-90 Microspheres for Hepatic Metastatic Neuroendocrine Tumors: A Prospective Single Center Study
    Kalinowski, Marc
    Dressler, Miriam
    Koenig, Alexander
    El-Sheik, Michael
    Rinke, Anja
    Hoeffken, Helmut
    Gress, Thomas M.
    Arnold, Rudolf
    Klose, Klaus-Jochen
    Wagner, Hans-Joachim
    DIGESTION, 2009, 79 (03) : 137 - 142
  • [29] Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors
    Desai, DC
    O'Dorisio, TM
    Schirmer, WJ
    Jung, SS
    Khabiri, H
    Villanueva, V
    Martin, EW
    REGULATORY PEPTIDES, 2001, 96 (03) : 113 - 117
  • [30] A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors
    Strosberg, J. R.
    Weber, J. M.
    Choi, J.
    Campos, T. L.
    Valone, T. L.
    Han, G.
    Schell, M. J.
    Kvols, L. K.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2335 - 2341
12345